Cormedix outlines $325M-$345M 2026 net revenue outlook amid TDAPA transition
CorMedix Inc. · PHARMACEUTICAL PREPARATIONS · Now $8.45
-4.8% in 1d after detection
Post-detection moves
1h
—
1d
-4.8%
3d
-1.4%
7d
+4.3%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS